| Institution: | 1. Department of Pharmacology, (the State‐Province Key Laboratories of Biomedicine‐Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, Heilongjiang, China;2. Department of Epidemiology and Biostatistics, Public Health School, Harbin Medical University, Harbin, Heilongjiang, China;3. Department of Cardiology, the First Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang, China;4. Division of Pathophysiology (the State‐Province Key Laboratories of Biomedicine‐Pharmaceutics of China and the Key Laboratory of Cardiovascular Research, Ministry of Education), Harbin Medical University, Harbin, Heilongjiang, China;5. Department of Cardiology, the Second Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang, China;6. Institute of Clinical Pharmacology, the Second Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang, China;7. Department of Pharmacology and Therapeutics, Melbourne School of Biomedical Sciences, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia |
